{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:33:22Z","timestamp":1697459602278},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.cancergencyto.2007.02.008","type":"journal-article","created":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T11:20:17Z","timestamp":1181128817000},"page":"125-131","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions"],"prefix":"10.1016","volume":"175","author":[{"given":"Ang\u00e8le","family":"Herry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Douet-Guilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Jos\u00e9e","family":"Le Bris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Morice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Fran\u00e7ois","family":"Abgrall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Berthou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"De Braekeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2007.02.008_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.leu.2401594","article-title":"Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere","volume":"14","author":"Andersen","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<282::AID-GCC9>3.0.CO;2-Z","article-title":"dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53","volume":"20","author":"Wang","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib5","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours","first-page":"61","article-title":"Myelodysplastic syndromes, acute myeloid leukaemias","author":"Brunning","year":"2001"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib6","article-title":"ISCN 1995: an international system for human cytogenetic nomenclature (1995)","year":"1995"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib7","first-page":"499","article-title":"Multicolor-FISH: the identification of chromosome aberrations by 24 colors","volume":"9","author":"Senger","year":"1998","journal-title":"BIOforum"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0165-4608(95)00136-0","article-title":"Rehybridization on metaphases studied previously by FISH","volume":"85","author":"Wang","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.V58.4.759.759","article-title":"Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease","volume":"58","author":"Rowley","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib10","first-page":"143","article-title":"Deletions of chromosome 5 in malignant myeloid disorders","volume":"15","author":"Le Beau","year":"1992","journal-title":"Cancer Surv"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01700373","article-title":"Cytogenetic findings in 179 patients with myelodysplastic syndromes","volume":"70","author":"Haase","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib12","first-page":"127","article-title":"Cytogenetics of myelodysplastic syndromes","volume":"33","author":"Fenaux","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/beha.2001.0151","article-title":"The cytogenetics of myelodysplastic syndromes","volume":"14","author":"Olney","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib14","first-page":"A3352","article-title":"Efficiency of fluorescence in situ hybridization (FISH) in cytogenetic study of hematological disorders","volume":"80","author":"Herry","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng0497-406","article-title":"Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping","volume":"15","author":"Veldman","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0165-4608(98)00137-X","article-title":"Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies","volume":"108","author":"Fleischman","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-4608(99)00142-9","article-title":"Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies","volume":"117","author":"Brezinova","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/gcc.20145","article-title":"Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study","volume":"42","author":"Andersen","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2003-06-2163","article-title":"Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies","volume":"103","author":"Poppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/gcc.10027","article-title":"Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q","volume":"34","author":"Mrozek","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0025-6196(12)60566-7","article-title":"Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes","volume":"60","author":"Knapp","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib22","first-page":"644","article-title":"Classifications of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH)","volume":"10","author":"Tosi","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mpo.2950230206","article-title":"Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on intergroup rhabdomyosarcoma. Study III: an interim report","volume":"23","author":"Heyn","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-4608(95)00278-2","article-title":"The use of FISH with chromosome-specific repetitive DNA probes for the follow-up of leukemia patients","volume":"88","author":"Arkerteijn","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-4608(90)90102-G","article-title":"Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia","volume":"46","author":"Lai","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s101470300009","article-title":"Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer","volume":"8","author":"Nakamori","year":"2003","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajh.2830480108","article-title":"Acute promyelocytic leukaemia (M3): relapse with acute myeloblastic leukaemia (M2) and dic(5;17)(q11;p11)","volume":"48","author":"Hatzis","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-4608(03)00218-8","article-title":"Characterization of psu dic(6;5)(p21.3;q13) with reverse chromosome painting in a patient with secondary myelodysplastic syndrome following treatment for multiple myeloma","volume":"148","author":"Lee-Jones","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jcp.41.4.378","article-title":"Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome","volume":"41","author":"Wilkie","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergencyto.2007.02.008_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","article-title":"High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients","volume":"101","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2003","journal-title":"Blood"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460807001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460807001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T19:53:37Z","timestamp":1587585217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460807001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0165460807001215"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2007.02.008","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}